Parkinson's disease: focus on management alternatives

Area of Science:

• Neurology
• Pharmacology

Background:

• Designed for healthcare professionals and payers.
• Focuses on the patient impact of Parkinson's disease (PD).

Purpose of the Study:

• To understand the impact of Parkinson's disease on patients.
• To identify optimized drug therapy strategies for improving patient quality of life.

Main Methods:

• Discussion of idiopathic Parkinson's disease (IPD) epidemiology and pathophysiology.
• Identification of secondary and drug-induced parkinsonism causes.
• Review of IPD manifestations and staging.
• Analysis of therapeutic alternatives for levodopa treatment failures.
• Examination of newer antiparkinsonian agents and established drug classes.

Main Results:

• Explores the multifaceted impact of Parkinson's disease on patients.
• Identifies specific drug classes and newer agents for Parkinson's disease management.
• Details mechanisms of action, adverse effects, and interactions for various antiparkinsonian drugs.

Conclusions:

• Optimizing drug therapy is crucial for improving the quality of life for Parkinson's disease patients.
• Understanding disease progression and treatment options is key for effective patient care.